Biomedical subjects

D R Barnard

Publications and source records attributed to D R Barnard.

At least 19 recordsLinked to original sources

PubMed2006

Laboratory evaluation of 21 insect repellents as larvicides and as oviposition deterrents of Aedes albopictus (Diptera: Culicidae).

Twenty-one commercial insect repellent products, including 12 botanical, 6 DEET-based, and 3 synthetic organics, were evaluated as larvicides and as oviposition deterrents of Aedes albopictus. Ten of the 12 botanical products at 0.1% concentration provided 57-100% mortality of laboratory-reared 4th-stage Ae. albopictus larvae at 24 h after treatment. Five of the 6 DEET-based products and 3 synthetic organic repellents at 0.1% concentration induced 88-100% larval mortality at 24 h after treatment. All 12 botanical products proved highly effective oviposition deterrents of Ae. albopictus, resulting in 76-100% effective repellency at 24 h after exposure. The 6 DEET-based repellents and the 3 synthetic organic repellents caused 84-100% effective oviposition repellency of Ae. albopictus at 24 h after exposure. Several botanical repellents previously shown to have minimal protection from mosquito bites proved effective oviposition deterrents. Some commercial topical repellents have good potential for development and use in management of container-inhabiting mosquitoes because they deter oviposition and kill larvae.

Aedes↗

PubMed2005

Treatment-related myelodysplastic syndrome/acute myeloid leukemia in survivors of childhood cancer--an update.

Treatment-related myelodysplastic syndrome/acute myeloid leukemia (t-MDS/t-AML) is a devastating complication of treatment for childhood cancer. However, the major cause of premature death of children treated for cancer remains their primary cancer. The understanding of the presentation, incidence, predisposing risk factors and pathobiology of t-MDS/t-AML is increasing. This increased understanding has not yet been translated into improved outcomes of therapy for t-MDS/t-AML. However, newer approaches are under study.

Acute Disease↗

PubMed2005

Effects of forced egg-retention in Aedes albopictus on adult survival and reproduction following application of DEET as an oviposition deterrent.

The insect repellent DEET (0.1% concentration), used as a mosquito oviposition deterrent in the laboratory, influenced the retention and maintenance of mature eggs by caged gravid female Aedes albopictus Skuse. This egg-retention mechanism could benefit survival because the gravid females were ultimately able to lay maintained eggs upon availability of water, but the length of forced egg-retention time reduced the number of eggs laid per female. Gravid females with retained eggs also laid a higher percentage of eggs that failed to tan, and this percentage increased with time duration of egg-retention. Percent egg hatch was not significantly affected by DEET when used as an oviposition deterrent; however, percent hatch was affected by time duration of egg-retention in both treated (exposed to DEET) and untreated (control) gravid females. The rate of egg hatch was considerably reduced after three weeks of retention; this reduction declined to zero for treated and control females at six and four weeks post-treatment, respectively. The fecundity and fertility of gravid female Ae. albopictus were affected by the time duration of forced egg-retention.

Aedes↗

PubMed2004

Childhood and maternal infections and risk of acute leukaemia in children with Down syndrome: a report from the Children's Oncology Group.

Children with Down syndrome (DS) are highly susceptible to acute leukaemia. Given the potential role of infections in the aetiology of leukaemia in children without DS, we investigated whether there was an association between early-life infections and acute leukaemia in children with DS. Maternal infections during pregnancy were also examined. We enrolled 158 incident cases of acute leukaemia in children with DS (97 acute lymphoblastic leukaemia (ALL) and 61 acute myeloid leukaemia (AML)) diagnosed at Children's Oncology Group institutions between 1997 and 2002. DS controls (N=173) were selected from the cases' primary care clinics and frequency matched on age at leukaemia diagnosis. Data were collected on demographics, child's medical history, mother's medical history, and other factors by maternal interview. Analyses were conducted using unconditional logistic regression adjusted for potential confounders. A significant negative association was observed between acute leukaemia and any infection in the first 2 years of life (adjusted odds ratio (OR)=0.55, 95% confidence interval (CI) (0.33-0.92); OR=0.53, 95% CI (0.29-0.97); and OR=0.59, 95% CI (0.28-1.25) for acute leukaemia combined, ALL, and AML respectively). The association between acute leukaemia and maternal infections during pregnancy was in the same direction but not significant. This study offers support for the hypothesis that early-life infections may play a protective role in the aetiology of acute leukaemia in children with DS.

Acute Disease↗

PubMed2001

A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission.

Intensive, myelosuppressive therapy is necessary to maximize outcomes for patients with acute myeloid leukemia (AML). A comparison was made of 3 aggressive postremission approaches for children and adolescents with AML in a randomized trial, CCG-2891. A total of 652 children and adolescents with AML who achieved remission on 2 induction regimens using identical drugs and doses (standard and intensive timing) were eligible for allocation to allogeneic bone marrow transplantation (BMT) based on matched related donor status (n = 181) or randomization to autologous BMT (n = 177) or to aggressive high-dose cytarabine-based chemotherapy (n = 179). Only 115 patients (18%) refused to participate in the postremission phase of this study. Overall compliance with the 3 allocated regimens was 90%. At 8 years actuarial, 54% +/- 4% (95% confidence interval) of all remission patients remain alive. Survival by assigned regimen ("intent to treat") is as follows: allogeneic BMT, 60% +/- 9%; autologous BMT, 48% +/- 8%; and chemotherapy, 53% +/- 8%. Survival in the allogeneic BMT group is significantly superior to autologous BMT (P =.002) and chemotherapy (P =.05); differences between chemotherapy and autologous BMT are not significant (P =.21). No potential confounding factors affected results. Patients receiving intensive-timing induction therapy had superior long-term survival irrespective of postremission regimen received (allogeneic BMT, 70% +/- 9%; autologous BMT, 54% +/- 9%; chemotherapy, 57% +/- 10%). Allogeneic BMT remains the treatment of choice for children and adolescents with AML in remission, when a matched related donor is available. For all others, there is no advantage to autologous BMT; hence, aggressive nonablative chemotherapy should be used.

Actuarial Analysis↗

PubMed2001

Low-concentration morphine infusion does not compromise packed red blood cell transfusion.

Regulations currently prohibit co-administration (through the same line) of red blood cell transfusions with continuous morphine infusions for pain management, resulting in additional intravenous access or interrupted analgesic therapy in seriously ill children. Packed cells that had been in contact with morphine 0.1 or 1.0 mg/mL and infused through a mock central venous catheter system showed no evidence of hemolysis when compared with control samples. There is thus no need to interrupt analgesic therapy or start another venous access line in order to give a coincident blood transfusion.

Analgesics, Opioid↗

PubMed2001

Laboratory and field evaluation of insect repellents as oviposition deterrents against the mosquito Aedes albopictus.

Three experimental approaches were used to evaluate the oviposition deterrency of three insect repellents, AI3-35765, AI3-37220 (piperidine compounds), and the standard N,N-diethyl-3-methylbenzamide (deet) to the mosquito Aedes albopictus Skuse (Diptera: Culicidae). Against laboratory-reared Ae. albopictus gravid females, the EC50 values of AI3-37220, AI3-35765 and deet were 0.004%, 0.008% and 0.011% in laboratory cages and 0.004%, 0.01% and 0.009% in an outdoor screened cage. For a natural population of Ae. albopictus tested in the field, the EC50 values were determined as 0.004%, 0.008% and 0.001%, respectively. Ageing concentrations of 0.1% of each repellent provided >50% effective oviposition deterrency against the laboratory population of Ae. albopictus for 13 days in laboratory cages, for 15 days in the outdoor cage, and for 21 days against field population of Ae. albopictus in Florida. These topical skin repellents are effective oviposition deterrents for Ae. albopictus when employed at relatively low application rates.

Aedes↗

PubMed2001

Laboratory and field evaluation of insect repellents as larvicides against the mosquitoes Aedes albopictus and Anopheles albimanus.

Acute toxicity and persistence of three insect repellents, deet and two piperidines (AI3-35765 and AI3-37220), were evaluated against mosquito larvae of Aedes albopictus (Skuse) and Anopheles albimanus Wiedemann (Diptera: Culicidae) in the laboratory, and against natural populations of Ae. albopictus in the field. In laboratory studies, the LC50 values of the repellents for first instars ranged between 0.005 and 0.021% (Ae. albopictus) and between 0.01 and 0.014% (An. albimanus) and, for fourth instars, between 0.019 and 0.034% (Ae. albopictus) and between 0.015 and 0.024% (An. albimanus). A 0.1% concentration of deet caused 90-100% mortality in first-instar Ae. albopictus for 4 weeks, whereas AI3-35765 and AI3-37220 at the same concentration killed 95-100% of larvae for 12 weeks and 98-100% of larvae for 33 weeks post-treatment, respectively. Deet and AI3-35765 at 0.1 % concentration resulted in complete mortality of first-instar An. albimanus for 3 weeks post-treatment, whereas AI3-37220 resulted in 91-99% larval mortalities for 35 weeks post-treatment. A 0.1% concentration of A13-37220 provided 77-98% larval mortality for 20 weeks and 63-97% larval mortality for 12 weeks post-treatment, respectively, against fourth-instar Ae. albopictus and An. albimanus. In the field, in artificial containers, the reduction of Ae. albopictus larvae caused by deet, AI3-35765 and AI3-37220 was 88-95% for 3-4 weeks, 98-100% for 7 weeks, and 82-100% for 13 weeks post-treatment, respectively. In used tyres, the same concentration of the repellents resulted in 100% reduction of Ae. albopictus larvae for 2 weeks (deet), 4 weeks (AI3-35765) and 5 weeks (AI3-37220) post-treatment. In cemetery flower vases, Aedes spp. larvae were eliminated for 4 weeks (deet) and 6 weeks post-treatment by both A13-35765 and AI3-37220. These topical repellents (particularly AI3-37220) have good potential for development and use in the management of container-inhabiting mosquitoes because they deter oviposition and kill larvae.

Aedes↗

PubMed2000

Analysis of human skin emanations by gas chromatography/mass spectrometry. 2. Identification of volatile compounds that are candidate attractants for the yellow fever mosquito (Aedes aegypti).

Volatile compounds emanated from human skin were studied by gas chromatography/mass spectrometry (GC/MS). The purpose of this study was to identify compounds that may be human-produced kairomones which are used for host location by the mosquito, Aedes aegypti (L.). The procedure used to collect volatiles was chosen because of prior knowledge that attractive substances can be transferred from skin to glass by handling. Laboratory bioassays have shown that the residuum on the glass remains attractive to mosquitoes until the compounds of importance evaporate. The sampling and analytical procedures modeled the above-cited process as closely as possible except that the evaporation of compounds from the glass surface was accomplished by thermal desorption from glass beads in a heated GC injection port. This made possible the solventless injection of volatiles onto the column. The compounds were cryofocused on the head of the column with liquid nitrogen prior to GC separation. A single stage of mass spectrometry on a triple quadrupole instrument was used for mass analysis. A combination of electron ionization and pulsed positive ion/negative ion chemical ionization modes on two different GC columns (one polar, one relatively nonpolar) was used to identify most of the 346 compound peaks detected by this technique.

Adult↗

PubMed1999

Repellency of essential oils to mosquitoes (Diptera: Culicidae).

The repellency of different concentrations (5, 10, 25, 50, 75, and 100%) and combinations of 5 essential oils (Bourbon geranium, cedarwood, clove, peppermint, and thyme) to Aedes aegypti (L.) and Anopheles albimanus Wiedemann when applied to human skin was determined in laboratory tests. Cedarwood oil failed to repel mosquitoes and only high concentrations of peppermint oil repelled Ae. aegypti. None of the oils tested prevented mosquito bite when used at the 5 or 10% concentration. Thyme and clove oils were the most effective mosquito repellents and provided 1 1/2 to 3 1/2 h of protection, depending on oil concentration. Clove oil (50%) combined with geranium oil (50%) or with thyme oil (50%) prevented biting by An. albimanus for 1 1/4 to 2 1/2 h. The potential for using essential oils as topical mosquito repellents may be limited by user acceptability; clove, thyme, and peppermint oils can be irritating to the skin, whereas both human subjects in this study judged the odor of clove and thyme oils unacceptable at concentrations > or = 25%.

Aedes↗

PubMed1999

Effects of partial blood engorgement and pretest carbohydrate availability on the repellency of deet to Aedes albopictus.

The pretest availability of 10% sucrose solution and/or partial blood engorgement in Aedes albopictus Skuse significantly influenced mosquito attack rates and the time of repellent protection in laboratory bioassays. In 46 cm L x 38 cm W x 37 cm H cages used in USDA repellent tests, non-blood-fed and partially blood-fed mosquitoes attempted to bite at similar rates. In small cages (5 cm dia. x 4 cm H), holding individual females, mean mosquito attack rates were reduced when females were partially blood fed, compared with those not blood fed. The protection period from bites by Ae. albopictus using 25% ethanolic deet (N,N diethyl-3-methylbenzamide) increased significantly in small and USDA standard cages when females had pretest access to sucrose solution, compared with females starved for 12 h. Partial blood engorgement in mosquitoes affected repellent protection time in USDA standard test cages but not in small cages.

Aedes↗

PubMed1998

Distinctive demography, biology, and outcome of acute myeloid leukemia and myelodysplastic syndrome in children with Down syndrome: Children's Cancer Group Studies 2861 and 2891.

In recent pediatric trials of acute myeloid leukemia (AML), children with Down syndrome (DS) have had significantly more megakaryoblastic leukemia and have experienced better outcome than other children. To further characterize AML in DS, Children's Cancer Group Studies 2861 and 2891 prospectively studied demography, biology, and response in AML and myelodysplastic syndrome (MDS) of children with and without DS. These studies evaluated timing of induction therapy and compared postremission chemotherapy with marrow transplantation in 1,206 children. One-hundred eighteen (9.8%) had DS, a fourfold increase in 20 years. DS patients were younger, had lower white blood cell and platelet counts, more antecedent MDS, acute megakaryoblastic leukemia or undifferentiated AML, and an under-representation of chromosomal translocations (P < .001 for each variable). Four-year event-free survival in DS was 69% versus 35% in others (P < .001). Intensively timed induction conferred significantly higher mortality in DS patients; bone marrow transplantation offered no advantage. Conventional induction followed by chemotherapy achieved an 88%, 4-year, disease-free survival in DS patients versus 42% in others (P < .001). Megakaryoblastic leukemia was unfavorable in others but prognostically neutral in DS. AML in DS is demographically and biologically distinct from AML in other children. It is singularly responsive to conventional chemotherapy and may warrant even less therapy. The increasing proportion of DS patients with AML most likely reflects changes in attitudes about entering DS patients on AML trials and possibly increasing ability to distinguish megakaryoblastic leukemia from lymphoid leukemia.

Acute Disease↗

PubMed1998

Mosquito density, biting rate and cage size effects on repellent tests.

Mosquito biting rates and the mean duration of protection (in hours) from bites (MDPB) of Aedes aegypti and Anopheles quadrimaculatus, using the repellent 'deet' (N,N-diethyl-3-methylbenzamide) on a 50 cm2 area of healthy human skin, were observed in small (27 l), medium (approximately 65 l) and large (125 l) cages containing low, medium or high densities of mosquitoes: respectively, 640, 128 or 49 cm3 of cage volume per female. At the initial treatment rate of approximately 0.4 microliter/cm2 (1 ml of 25% deet in ethanol on 650 cm2 of skin), the MDPB for deet against Ae. aegypti ranged from 4.5 to 6.5 h and was significantly less (5.0 +/- 0.8 h) in large cages compared with medium (6.2 +/- 0.9 h) and small (6.2 +/- 0.8 h) cages, regardless of the density. Against An. quadrimaculatus the MDPB for deet 0.4 microliter/cm2 was 1.5-8.0 h, less in small (3.7 +/- 2.3 h) and large (2.2 +/- 1.1 h) cages at medium (3.7 +/- 2.3 h) and high (2.5 +/- 1.7 h) mosquito densities, and was longest in medium cages (6.2 +/- 2.6 h) at low mosquito densities (5.8 +/- 2.8 h). With equinoxial photoperiodicity (light on 06.00-18.00 hours) the biting rate was influenced by the time of observation (08.00, 12.00, 16.00 hours) for Ae. aegypti but not for An. quadrimaculatus. For both species, the biting rate was inversely proportional to mosquito density and the MDPB. The shortest MDPBs were obtained in large cages with high densities of mosquitoes and longest protection times occurred in medium sized cages with low mosquito densities.

Aedes↗

PubMed1998

Triple cage olfactometer for evaluating mosquito (Diptera: Culicidae) attraction responses.

A triple cage olfactometer for evaluating mosquito attraction responses is described. The olfactometer is designed for easy access for interior cleaning, has a mechanism that allows synchronous operation of the port doors on each cage, and requires 0.8 m2 of floor space. It is constructed of clear acrylic, contains 3 test chambers in a tiered configuration, has paired removable sleeves and mosquito traps on each cage, and is equipped with a filtered external air supply system that has temperature and relative humidity control.

Animals↗

PubMed1998

Mediation of deet repellency in mosquitoes (Diptera: Culicidae) by species, age, and parity.

Laboratory bioassays assessed differences in the protection time provided by the repellent deet (N,N-diethyl-3-methylbenzamide) against 5-d-old nulliparous and 10-, 15-, and 20-d-old nulliparous and parous female Aedes aegypti (L.), Anopheles albimanus (Weidemann), and Anopheles quadrimaculatus Say sensu lato. Mean protection time was shortest against An. albimanus (1.6 h) and An. quadrimaculatus (1.5 h) and longest against Ae. aegypti (6.5 h), but was not significantly influenced by mosquito age or parity. Mean percentage of biting at repellent failure time was highest in An. albimanus (14.2%), followed by An. quadrimaculatus (7.0%) and Ae. aegypti (2.9%), was higher in parous females (10.8%) than in nulliparous females (5.9%), and was highest overall (35%) in 20-d-old parous An. albimanus. Interaction between mosquito species and parity and between parity and age factors, respectively, resulted from a significant decrease in percentage of biting by parous An. quadrimaculatus compared with other females, and a significant increase in biting by 20-d-old parous females compared with other females. The main finding of this study is that repellent protection time is unaffected by parity; this is important because parous mosquitoes are the primary target of personal-protection measures in disease-endemic areas. When repellent failure did occur, there was a higher risk of bite by old, parous An. albimanus than for any other species, age, or parity grouping of females.

Aedes↗

PubMed1997

Parasites of the Asian tiger mosquito and other container-inhabiting mosquitoes (Diptera:Culicidae) in northcentral Florida.

Seven microorganisms including 4 protozoans, 2 fungi, and a bacterium infected Aedes albopictus (Skuse) larvae collected from 12 counties in northecentral Florida. Ae albopictus and 14 other species of mosquitoes were collected from tires, flower-holding vases in cemeteries, other types of artificial containers, and treeholes. Ascogregarina taiwanensis (Lien & Levine) was the most common parasite of Ae. albopictus throughout the year. The microsporidium Vavraia culicis (Weiser) infected Aedes aegypti (L.), Ae. albopictus, Aedes triseriatus (Say), and Orthopodomyia sinifera (Coquillett). A vibrio bacterium and 2 fungi (Leptolegnia sp. and Smittium culisetae Lichtwardt), infected Ae. albopictus larvae but were observed infrequently. A. taiwanensis, S. culisetae, and the vibrio bacterium previously have been reported from Ae. albopictus. This is the 1st report of the other 4 microorganisms parasitizing Ae. albopictus larvae.

Aedes↗

PubMed1997

Diel patterns of pupation, emergence, and oviposition in a laboratory population of Aedes albopictus.

There was no apparent daily pattern of pupation in Aedes albopictus in the laboratory [14:10 h (L:D); lights on: 0600 h, lights off: 2000 h], but diel patterns of emergence and oviposition were influenced by mosquito body size. Emergence rate was highest in large-bodied male mosquitoes at 1600 h and in small males at 1000 h but was lowest in large and small males, respectively, at 2400 h and 0200 h. Peak emergence of females was at 1600 h, regardless of body size; lowest emergence was at 0400 h. Half of all ovipositions by large females in their first gonotrophic cycle (GC1) were at 2000 and 2200 h but at 1800 to 2000 h in the second gonotrophic cycle (GC2). In small females, oviposition in GC1 and GC2 was highest at 1800 and 1600 h, respectively, and lowest at 0400 h. Half of all ovipositions in small females were at 1600 to 1800 h.

Aedes↗

PubMed1996

Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.

Timed sequencing of cycles of induction chemotherapy in acute myeloid leukemia (AML) has been proposed as a way to achieve maximal leukemic cell kill through recruitment and synchronization of residual neoplastic cells. Furthermore, whether intensive induction therapy should be continued in the presence of profound myelosuppression is an important question. The Children's Cancer Group (CCG) conducted a prospective randomized trial in which 589 patients with AML were randomized at diagnosis to one of two induction approaches involving a 4-day cycle of five active chemotherapeutic agents, with the second cycle administered either 10 days after the first cycle, despite low or dropping blood counts (intensive timing), or 14 days or later from the beginning of the first cycle, depending on bone marrow status (standard timing). All patients achieving remission received a total of four cycles of induction therapy. They were then allocated to allogeneic bone marrow transplantation (BMT) if a compatible family donor was present or randomized to aggressive nonmyeloablative therapy or to myeloablative therapy with purged autologous BMT rescue. The three postremission arms remain coded. Induction success and median days to complete induction were similar for the 295 patients randomized to the intensive timing arm (75%, 99 days) compared with the 294 patients randomized to the standard timing arm (70%, 105 days; P = .18 for remission). However, a marked improvement in outcome was demonstrated in patients randomized to the intensive timing arm, with an actuarial event-free survival at 3 years of 42% +/- 7% (95% confidence interval [CI]) versus 27% +/- 6% for patients on the standard timing arm (P = .0005). Disease-free survival results at 3 years from the end of induction were superior for patients receiving intensively timed induction therapy (N = 211), 55% +/- 9% versus 37% +/- 9% for standard timing patients (N = 195, P = .0002), with a median follow-up from achieving remission of 28 months. Superior results were documented for patients receiving intensive timing irrespective of the postremission therapy to which they were allocated. Intensively timed induction therapy for patients with AML markedly improves event-free survival, even for patients undergoing myeloablative therapy with BMT rescue. Without controlling for the type of induction therapy received, results of various BMT studies in AML comparing different preparative regimens will be difficult to interpret.

Acute Disease↗